相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus
Raymond T. Chung et al.
HEPATOLOGY (2015)
EVALUATION OF THE PAN-GENOTYPIC HCV NS3/4A PROTEASE INHIBITOR GS-9857 IN HEALTHY VOLUNTEERS
B. Kirby et al.
JOURNAL OF HEPATOLOGY (2015)
PRECLINICAL PROFILE OF THE PAN-GENOTYPIC HCV NS3/4A PROTEASE INHIBITOR GS-9857
J. G. Taylor et al.
JOURNAL OF HEPATOLOGY (2015)
The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment
Brian P. Lam et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2015)
The New Era of Interferon-Free Treatment of Chronic Hepatitis C
Philipp Solbach et al.
VISZERALMEDIZIN (2015)
Implications of baseline polymorphisms for potential resistance to NS3 protease inhibitors in Hepatitis C virus genotypes 1a, 2b and 3a
Navaneethan Palanisamy et al.
ANTIVIRAL RESEARCH (2013)
In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435
Oliver Lenz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Rapid HCV-RNA Decline With Once Daily TMC435: A Phase I Study in Healthy Volunteers and Hepatitis C Patients
Henk W. Reesink et al.
GASTROENTEROLOGY (2010)
Characterization of Resistance to the Protease Inhibitor Boceprevir in Hepatitis C Virus-Infected Patients
Simone Susser et al.
HEPATOLOGY (2009)
Characterization of resistance mutations against HCV ketoamide protease inhibitors
Xiao Tong et al.
ANTIVIRAL RESEARCH (2008)
Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir
Christoph Sarrazin et al.
GASTROENTEROLOGY (2007)
Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034
Xiao Tong et al.
ANTIVIRAL RESEARCH (2006)
分享论文
